https://www.selleckchem.com/pr....oducts/anidulafungin
The neuromuscular complications of cancer therapy include chemotherapy-induced peripheral neurotoxicity (CIPN), immune-related neuromuscular complications to immune checkpoint inhibitors and radiation-induced neuropathy/plexopathy. With a wider focus on CIPN, we will discuss new pathogenetic insights, recent predictive biomarkers and emerging therapies for neuromuscular complications of cancer therapy. Findings from recent preclinical studies have improved our knowledge on new CIPN pathogenetic pathways, including the act
Aimer
Commentaire
Partagez
